Armida Labs, Inc. uses innovative drug discovery technologies and approaches aimed at developing covalent drugs targeting His, Lys, or Tyr residues, hence beyond Cys. Our strategies can be deployed to improve the pharmacodynamics and pharmacokinetics properties of drugs,  and to target challenging drug targets, such as those involved in protein-protein interactions. 

For more info email